The Canadian journal of cardiology
-
Practice Guideline Comparative Study Guideline
The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
To provide updated, evidence-based recommendations for the management of hypertension in adults. ⋯ All recommendations were graded according to the strength of the evidence and voted on by the Canadian Hypertension Education Program Evidence-Based Recommendations Task Force. Individuals with irreconcilable competing interests (declared by all members, compiled and circulated before the meeting) relative to any specific recommendation were excluded from voting on that recommendation. Only recommendations achieving at least 70% consensus are reported here. These guidelines will continue to be updated annually.
-
Review Case Reports
Impending paradoxical embolus: a case report and review of the literature.
A case of a 43-year-old man with impending paradoxical embolism (IPE) is described. The patient initially presented with pulmonary embolism and was diagnosed with an IPE on transthoracic and transesophageal echocardiography. ⋯ This report discusses the main clinical features, the diagnostic role of echocardiography and the outcome of medical and surgical treatment strategies in patients with IPE. Based on the literature to date, we recommend that patients with impending paradoxical embolism be treated with initial systemic heparinization followed by emergent surgical embolectomy if the surgical risks are acceptable.
-
Case Reports
Ventricular septal defect secondary to penetrating trauma without pericardial effusion.
Incidence of penetrating cardiac trauma is on the rise. With improved trauma care, an increasing number of these patients arrive at the hospital alive. An unusual case of penetrating cardiac trauma is presented that highlights the importance of thorough echocardiographic assessment of such patients.
-
The National Cholesterol Education Program Adult Treatment Panel (ATP) III recommendations incorporate new evidence for treating elevated low-density lipoprotein cholesterol. ⋯ A 10% reduction in overweight and obesity prevalence could have prevented 69,530 cases of drug eligibility in 2001. On the other hand, by 2011 over one million Canadians will be drug-eligible because of an elevated body mass index, if the recent trends in overweight and obese status continue.